Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896285 · ClinicalTrials.gov registry record · NA
The First Therapeutic Intervention in Malignant Pleural Effusion Trial
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00896285 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 4 participants.
The verdict
NCT00896285, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Fluid caused by cancer cells may accumulate in the lining of the lung. Draining the fluid with a chest tube may relieve pain and shortness of breath. To stop the fluid from coming back again, patients are given a medicine (talc) into the chest drain to seal up the space around the lung. This procedure is known as pleurodesis. This sometimes causes pain and discomfort, and the investigators do not know the best way of preventing this. The investigators hope to find the best way to prevent pain during pleurodesis.
Interventions
- OTHER Large bore chest drain + NSAID based analgesic regimen
- OTHER Small bore chest drain + NSAID based analgesic regimen
- OTHER Large bore chest drain + opiate based analgesic regimen
- OTHER Small bore chest drain + opiate based analgesic regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00896285
The ClinicalTrials.gov registry entry for NCT00896285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Large bore chest drain + NSAID based analgesic regimen is the first listed.
NCT00896285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00896285 about?
NCT00896285 is a clinical study titled "The First Therapeutic Intervention in Malignant Pleural Effusion Trial". Fluid caused by cancer cells may accumulate in the lining of the lung. Draining the fluid with a chest tube may relieve pain and shortness of breath. To stop the fluid from coming back again, patients are given a medicine (talc) into the chest drain to seal up the space around the lung. This procedu...
What is the current status of trial NCT00896285?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00896285?
The interventions under investigation include: Large bore chest drain + NSAID based analgesic regimen (OTHER), Small bore chest drain + NSAID based analgesic regimen (OTHER), Large bore chest drain + opiate based analgesic regimen (OTHER), Small bore chest drain + opiate based analgesic regimen (OTHER).
Who is sponsoring clinical trial NCT00896285?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.